These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9796882)

  • 1. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus.
    Ishiyama-Shigemoto S; Yamada K; Yuan X; Koyama W; Nonaka K
    Diabet Med; 1998 Oct; 15(10):826-9. PubMed ID: 9796882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians.
    Hart LM; de Knijff P; Dekker JM; Stolk RP; Nijpels G; van der Does FE; Ruige JB; Grobbee DE; Heine RJ; Maassen JA
    Diabetologia; 1999 May; 42(5):617-20. PubMed ID: 10333056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the relationship between sulfonylurea receptor 1 gene polymorphism and type 2 diabetes mellitus].
    Wang JS; Zhou L; Cheng JL; Shen MY
    Yi Chuan; 2004 Jan; 26(1):8-12. PubMed ID: 15626659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab.
    Matharoo K; Arora P; Bhanwer AJ
    Gene; 2013 Sep; 527(1):228-34. PubMed ID: 23764562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
    Gloyn AL; Hashim Y; Ashcroft SJ; Ashfield R; Wiltshire S; Turner RC;
    Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
    Zychma MJ; Gumprecht J; Strojek K; Grzeszczak W; Moczulski D; Trautsolt W; Karasek D
    Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients.
    Dworacka M; Winiarska H; Jagodziński PP
    Diabetes Res Clin Pract; 2007 Aug; 77(2):258-62. PubMed ID: 17207885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
    Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J
    Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.
    Ohta Y; Tanizawa Y; Inoue H; Hosaka T; Ueda K; Matsutani A; Repunte VP; Yamada M; Kurachi Y; Bryan J; Aguilar-Bryan L; Permutt MA; Oka Y
    Diabetes; 1998 Mar; 47(3):476-81. PubMed ID: 9519757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exon 16-3t variant of the sulphonylurea receptor gene is not a risk factor for Type II diabetes mellitus in the Dutch Breda cohort.
    van Tilburg JH; Rozeman LB; van Someren H; Rigters-Aris CA; Freriks JP; Pearson PL; Sandkuijl LA; van Haeften TW; Wijmenga C
    Diabetologia; 2000 May; 43(5):681-2. PubMed ID: 10855544
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
    Meirhaeghe A; Helbecque N; Cottel D; Arveiler D; Ruidavets JB; Haas B; Ferrières J; Tauber JP; Bingham A; Amouyel P
    Am J Med Genet; 2001 Jun; 101(1):4-8. PubMed ID: 11343328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects.
    Yokoi N; Kanamori M; Horikawa Y; Takeda J; Sanke T; Furuta H; Nanjo K; Mori H; Kasuga M; Hara K; Kadowaki T; Tanizawa Y; Oka Y; Iwami Y; Ohgawara H; Yamada Y; Seino Y; Yano H; Cox NJ; Seino S
    Diabetes; 2006 Aug; 55(8):2379-86. PubMed ID: 16873704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy.
    Nikolac N; Simundic AM; Saracevic A; Katalinic D
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):924-30. PubMed ID: 22533711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.
    Inoue H; Ferrer J; Welling CM; Elbein SC; Hoffman M; Mayorga R; Warren-Perry M; Zhang Y; Millns H; Turner R; Province M; Bryan J; Permutt MA; Aguilar-Bryan L
    Diabetes; 1996 Jun; 45(6):825-31. PubMed ID: 8635661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
    Gloyn AL; Weedon MN; Owen KR; Turner MJ; Knight BA; Hitman G; Walker M; Levy JC; Sampson M; Halford S; McCarthy MI; Hattersley AT; Frayling TM
    Diabetes; 2003 Feb; 52(2):568-72. PubMed ID: 12540637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.